NCT05431868View on ClinicalTrials.gov

Objective and Subjective Outcomes of a Trifocal IOL in Eyes With Different AL

CompletedOBSERVATIONAL
Enrollment

61

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

January 31, 2021

Study Completion Date

December 31, 2021

Conditions
CataractPresbyopiaLenses, IntraocularMyopiaSatisfaction
Interventions
OTHER

AT LISA tri 839MP (Carl Zeiss Meditec AG)

This prospective cohort study collected data of patients who underwent bilateral or unilateral cataract surgery with the AT LISA tri 839MP implantation.

Trial Locations (1)

100191

Peking University Third Hospital, Beijing

All Listed Sponsors
lead

Peking University Third Hospital

OTHER

NCT05431868 - Objective and Subjective Outcomes of a Trifocal IOL in Eyes With Different AL | Biotech Hunter | Biotech Hunter